Iron oxide-based nanovector for tumor targeted siRNA delivery in an orthotopic hepatocellular carcinoma xenograft mouse model

Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. Small interfering RNA (siRNA) holds promise as a new class of therapeutics for HCC as it can achieve sequence-specific gene knockdown with low cytotoxicity. However, the main challenge in the clinical application of siRNA lies...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Small
Autors principals: Wang, Kui, Kievit, Forrest M., Sham, Jonathan G., Jeon, Mike, Stephen, Zachary R., Bakthavatsalam, Arvind, Park, James O., Zhang, Miqin
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829640/
https://ncbi.nlm.nih.gov/pubmed/26641029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201501985
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars